Compile Data Set for Download or QSAR
maximum 50k data
Found 56 with Last Name = 'klitgaard' and Initial = 'h'
TargetD(2) dopamine receptor(Homo sapiens (Human))
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM21398(4-[4-(4-Chloro-phenyl)-4-hydroxy-piperidin-1-yl]-1...)
Affinity DataKi:  0.794nMAssay Description:In vitro binding affinity for Dopamine receptor D2More data for this Ligand-Target Pair
In DepthDetails ArticlePubMedDrugBank

TargetD(4) dopamine receptor(Homo sapiens (Human))
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM21398(4-[4-(4-Chloro-phenyl)-4-hydroxy-piperidin-1-yl]-1...)
Affinity DataKi:  1.60nMAssay Description:In vitro binding affinity for Dopamine receptor D4More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerotonin 2 (5-HT2) receptor(Homo sapiens (Human))
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM50001884(2-[4-(4-Methyl-benzyl)-piperazin-1-yl]-1-(2-methyl...)
Affinity DataKi:  5nMAssay Description:In vitro binding affinity for 5-hydroxytryptamine 2 receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetD(4) dopamine receptor(Homo sapiens (Human))
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM50001884(2-[4-(4-Methyl-benzyl)-piperazin-1-yl]-1-(2-methyl...)
Affinity DataKi:  16nMAssay Description:In vitro binding affinity for Dopamine receptor D4More data for this Ligand-Target Pair
In DepthDetails ArticlePubMedDrugBank

TargetSerotonin 2 (5-HT2) receptor(Homo sapiens (Human))
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM21398(4-[4-(4-Chloro-phenyl)-4-hydroxy-piperidin-1-yl]-1...)
Affinity DataKi:  20nMAssay Description:In vitro binding affinity for 5-hydroxytryptamine 2 receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerotonin 2 (5-HT2) receptor(Homo sapiens (Human))
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM50218629(CHEMBL282927)
Affinity DataKi:  32nMAssay Description:In vitro binding affinity for 5-hydroxytryptamine 2 receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetD(2) dopamine receptor(Homo sapiens (Human))
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM50001884(2-[4-(4-Methyl-benzyl)-piperazin-1-yl]-1-(2-methyl...)
Affinity DataKi:  32nMAssay Description:In vitro binding affinity for Dopamine receptor D2More data for this Ligand-Target Pair
In DepthDetails ArticlePubMedDrugBank

TargetD(2) dopamine receptor(Homo sapiens (Human))
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM50095890(2-[2-(4-Dibenzo[b,f][1,4]thiazepin-11-yl-1-piperaz...)
Affinity DataKi:  63nMAssay Description:In vitro binding affinity for Dopamine receptor D2More data for this Ligand-Target Pair
In DepthDetails ArticlePubMedDrugBank

TargetD(2) dopamine receptor(Homo sapiens (Human))
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM50218629(CHEMBL282927)
Affinity DataKi:  100nMAssay Description:In vitro binding affinity for Dopamine receptor D2More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetD(4) dopamine receptor(Homo sapiens (Human))
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM50218629(CHEMBL282927)
Affinity DataKi:  158nMAssay Description:In vitro binding affinity for Dopamine receptor D4More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerotonin 2 (5-HT2) receptor(Homo sapiens (Human))
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM50095890(2-[2-(4-Dibenzo[b,f][1,4]thiazepin-11-yl-1-piperaz...)
Affinity DataKi:  220nMAssay Description:In vitro binding affinity for 5-hydroxytryptamine 2 receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSynaptic vesicle glycoprotein 2A(Rattus norvegicus)
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM50422558(CHEMBL434705)
Affinity DataIC50:  79.4nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteChecked by AuthorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSynaptic vesicle glycoprotein 2A(Rattus norvegicus)
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM50422517(CHEMBL149348)
Affinity DataIC50:  100nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteChecked by AuthorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSynaptic vesicle glycoprotein 2A(Rattus norvegicus)
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM50422531(BRIVARACETAM | UCB-34714)
Affinity DataIC50:  100nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteChecked by AuthorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSynaptic vesicle glycoprotein 2A(Rattus norvegicus)
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM50422518(CHEMBL358242)
Affinity DataIC50:  125nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteChecked by AuthorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSynaptic vesicle glycoprotein 2A(Rattus norvegicus)
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM50422548(CHEMBL150241)
Affinity DataIC50:  125nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteChecked by AuthorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSynaptic vesicle glycoprotein 2A(Rattus norvegicus)
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM50422525(CHEMBL348187)
Affinity DataIC50:  158nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteChecked by AuthorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSynaptic vesicle glycoprotein 2A(Rattus norvegicus)
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM50422519(CHEMBL358393)
Affinity DataIC50:  199nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteChecked by AuthorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSynaptic vesicle glycoprotein 2A(Rattus norvegicus)
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM50422522(CHEMBL347071)
Affinity DataIC50:  251nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteChecked by AuthorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSynaptic vesicle glycoprotein 2A(Rattus norvegicus)
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM50422540(CHEMBL152911)
Affinity DataIC50:  251nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteChecked by AuthorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSynaptic vesicle glycoprotein 2A(Rattus norvegicus)
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM50422533(CHEMBL150331)
Affinity DataIC50:  398nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteChecked by AuthorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSynaptic vesicle glycoprotein 2A(Rattus norvegicus)
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM50422526(CHEMBL359062)
Affinity DataIC50:  398nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteChecked by AuthorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSynaptic vesicle glycoprotein 2A(Rattus norvegicus)
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM50422556(CHEMBL358161)
Affinity DataIC50:  501nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteChecked by AuthorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSynaptic vesicle glycoprotein 2A(Rattus norvegicus)
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM50422523(CHEMBL358239)
Affinity DataIC50:  794nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteChecked by AuthorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSynaptic vesicle glycoprotein 2A(Rattus norvegicus)
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM50422542(Keppra | Keppra Xr | LEVETIRACETAM | Levetiracetam...)
Affinity DataIC50:  794nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteChecked by AuthorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSynaptic vesicle glycoprotein 2A(Rattus norvegicus)
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM50422541(CHEMBL149400)
Affinity DataIC50:  1.25E+3nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteChecked by AuthorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSynaptic vesicle glycoprotein 2A(Rattus norvegicus)
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM50422555(CHEMBL346223)
Affinity DataIC50:  1.25E+3nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteChecked by AuthorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSynaptic vesicle glycoprotein 2A(Rattus norvegicus)
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM50422545(CHEMBL345318)
Affinity DataIC50:  1.25E+3nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteChecked by AuthorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSynaptic vesicle glycoprotein 2A(Rattus norvegicus)
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM50422544(CHEMBL154983)
Affinity DataIC50:  1.25E+3nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteChecked by AuthorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSynaptic vesicle glycoprotein 2A(Rattus norvegicus)
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM50422536(CHEMBL421785)
Affinity DataIC50:  1.58E+3nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteChecked by AuthorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSynaptic vesicle glycoprotein 2A(Rattus norvegicus)
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM50422549(CHEMBL150791)
Affinity DataIC50:  1.58E+3nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteChecked by AuthorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSynaptic vesicle glycoprotein 2A(Rattus norvegicus)
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM50422543(CHEMBL153264)
Affinity DataIC50:  1.99E+3nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteChecked by AuthorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSynaptic vesicle glycoprotein 2A(Rattus norvegicus)
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM50422534(CHEMBL153282)
Affinity DataIC50:  1.99E+3nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteChecked by AuthorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSynaptic vesicle glycoprotein 2A(Rattus norvegicus)
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM50422553(CHEMBL151650)
Affinity DataIC50:  1.99E+3nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteChecked by AuthorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSynaptic vesicle glycoprotein 2A(Rattus norvegicus)
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM50422551(CHEMBL358877)
Affinity DataIC50:  1.99E+3nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteChecked by AuthorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSynaptic vesicle glycoprotein 2A(Rattus norvegicus)
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM50422538(CHEMBL154863)
Affinity DataIC50:  2.51E+3nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteChecked by AuthorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSynaptic vesicle glycoprotein 2A(Rattus norvegicus)
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM50422532(CHEMBL150281)
Affinity DataIC50:  2.51E+3nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteChecked by AuthorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSynaptic vesicle glycoprotein 2A(Rattus norvegicus)
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM50422552(CHEMBL153690)
Affinity DataIC50:  2.51E+3nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteChecked by AuthorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSynaptic vesicle glycoprotein 2A(Rattus norvegicus)
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM50422529(CHEMBL150393)
Affinity DataIC50:  3.16E+3nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteChecked by AuthorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSynaptic vesicle glycoprotein 2A(Rattus norvegicus)
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM50422524(CHEMBL440539)
Affinity DataIC50:  3.98E+3nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteChecked by AuthorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSynaptic vesicle glycoprotein 2A(Rattus norvegicus)
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM50422527(CHEMBL151072)
Affinity DataIC50:  3.98E+3nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteChecked by AuthorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSynaptic vesicle glycoprotein 2A(Rattus norvegicus)
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM50422550(CHEMBL2111197)
Affinity DataIC50:  5.01E+3nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteChecked by AuthorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSynaptic vesicle glycoprotein 2A(Rattus norvegicus)
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM50422557(CHEMBL607346)
Affinity DataIC50:  6.30E+3nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteChecked by AuthorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSynaptic vesicle glycoprotein 2A(Rattus norvegicus)
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM50422554(CHEMBL607297)
Affinity DataIC50:  6.30E+3nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteChecked by AuthorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSynaptic vesicle glycoprotein 2A(Rattus norvegicus)
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM50422520(CHEMBL150903)
Affinity DataIC50:  9.99E+3nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteChecked by AuthorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSynaptic vesicle glycoprotein 2A(Rattus norvegicus)
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM50422521(CHEMBL607343)
Affinity DataIC50:  1.25E+4nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteChecked by AuthorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSynaptic vesicle glycoprotein 2A(Rattus norvegicus)
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM50422537(CHEMBL153180)
Affinity DataIC50:  1.25E+4nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteChecked by AuthorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSynaptic vesicle glycoprotein 2A(Rattus norvegicus)
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM50422530(CHEMBL346199)
Affinity DataIC50:  1.58E+4nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteChecked by AuthorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSynaptic vesicle glycoprotein 2A(Rattus norvegicus)
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM50422535(CHEMBL607399)
Affinity DataIC50:  1.99E+4nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteChecked by AuthorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSynaptic vesicle glycoprotein 2A(Rattus norvegicus)
Ucb Pharma

Curated by ChEMBL
LigandPNGBDBM50422546(CHEMBL153729)
Affinity DataIC50:  1.99E+4nMAssay Description:In vitro inhibitory activity against [3H](2S)-2-[4-(3-azidophenyl)-2-oxopyrrolidin-1-yl]butanamide binding to levetiracetam binding siteChecked by AuthorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Displayed 1 to 50 (of 56 total ) | Next | Last >>
Jump to: